Literature DB >> 15911430

Hepatitis E is a cause of unexplained hepatitis in The Netherlands.

K Waar1, M M P T Herremans, H Vennema, M P G Koopmans, C A Benne.   

Abstract

BACKGROUND: Hepatitis E virus (HEV) is the major etiologic agent of enterically transmitted viral hepatitis in much of the developing world. Evidence provided in recent years shows that HEV is also prevalent in very low numbers in non-endemic countries. Recently, a cluster of three patients with acute hepatitis E but no history of travel to endemic countries was discovered in the geographical area provided with service by the Public Health Laboratory Groningen and Drenthe, The Netherlands.
OBJECTIVE: This lead to the question whether hepatitis E is a cause of unexplained hepatitis in this district. STUDY
DESIGN: The prevalence of anti-HEV IgG and IgM among 209 patients with clinical signs of hepatitis, negative test for hepatitis A-C, no history of foreign travel and no other cause of hepatocellular damage was compared with a matched control group of 209 individuals.
RESULTS: We found a significant difference in seroprevalence between the two groups for IgG anti-HEV as determined with the Abbot HEV EIA (6.2% versus 0.5%); however this difference could not be confirmed with the Genelabs Diagnostics HEV IgG ELISA (6.7% versus 3.8%). For confirmed cases of IgM anti-HEV we also detected a significant difference between the two groups (3.3% versus 0.5%). Remarkably, the combination of IgG and IgM anti-HEV was only found among hepatitis patients.
CONCLUSION: This study provides evidence of locally acquired hepatitis E in The Netherlands. Therefore, in cases of unexplained acute hepatitis, the diagnosis of hepatitis E should be considered even in the absence of foreign travel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15911430     DOI: 10.1016/j.jcv.2004.10.015

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  16 in total

1.  Jaundice in a traveler returning from India.

Authors:  Aaron Woofter; Norman Sussman
Journal:  MedGenMed       Date:  2006-02-16

2.  Prevalence of hepatitis E virus infection in children in the northeast of Spain.

Authors:  Maria Buti; Pere Plans; Angela Domínguez; Rossend Jardi; Francisco Rodriguez Frias; Rafael Esteban; Luis Salleras; Antoni Plasencia
Journal:  Clin Vaccine Immunol       Date:  2008-03-05

3.  Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3.

Authors:  M Herremans; E Duizer; E Jusic; M P G Koopmans
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

4.  Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance.

Authors:  Sally A Baylis; Kay-Martin Hanschmann; Johannes Blümel; C Micha Nübling
Journal:  J Clin Microbiol       Date:  2011-02-09       Impact factor: 5.948

Review 5.  Autochthonous hepatitis e virus infections: a new transfusion-associated risk?

Authors:  Jens Dreier; David Juhl
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

6.  Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system.

Authors:  Masaharu Takahashi; Toshinori Tanaka; Masahiro Azuma; Eiji Kusano; Tatsuya Aikawa; Takao Shibayama; Yasuyuki Yazaki; Hitoshi Mizuo; Jun Inoue; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

7.  Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity.

Authors:  M Herremans; J Bakker; E Duizer; H Vennema; M P G Koopmans
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

8.  Sources of hepatitis E virus genotype 3 in The Netherlands.

Authors:  Saskia A Rutjes; Willemijn J Lodder; Froukje Lodder-Verschoor; Harold H J L van den Berg; Harry Vennema; Erwin Duizer; Marion Koopmans; Ana Maria de Roda Husman
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

9.  Hepatitis E virus antibodies in patients with chronic liver disease.

Authors:  Muslim Atiq; Norah J Shire; Anna Barrett; Susan D Rouster; Kenneth E Sherman; Mohamed T Shata
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

10.  Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004 - 2006.

Authors:  Katrine Borgen; Tineke Herremans; Erwin Duizer; Harry Vennema; Saskia Rutjes; Arnold Bosman; Ana Maria de Roda Husman; Marion Koopmans
Journal:  BMC Infect Dis       Date:  2008-05-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.